Evolving New Treatment for Myelodysplastic Syndromes

被引：0
作者：
Yataro Yoshida
机构：
[1] Takeda General Hospital,
来源：
International Journal of Hematology | 2007年 / 86卷
关键词：
Myelodysplastic syndromes; Treatment; Classification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Over the last several years, there has been substantial progress in the definition, diagnosis, and management of myelodysplastic syndromes (MDSs). This progress includes the new World Health Organization classification and the revised standardized response criteria to be applicable to most new compounds, which, taken together with the International Prognostic Scoring System, provide a uniform basis for the management of individual patients. The recent introduction of certain new agents, as well as an apparent increase in the use of stem cell transplantation with a variety of so-called reduced-intensity settings, has indeed raised the hope that we are entering a new era of MDS treatment.
引用
收藏
页码：297 / 300
页数：3
相关论文
共 62 条
  • [1] Bennett JM(1982)Proposal for the classification of the myelodysplastic syndromes Br J Haematol 51 189-199
  • [2] Catovsky D(2006)Myelodysplasia: when to treat and how Best Pract Res Clin Haematol 19 293-300
  • [3] Daniel MT(2006)The myelodysplastic syndromes: diagnosis and treatment Mayo Clin Proc 81 104-130
  • [4] Larson RA(2005)Strategies for biology- and molecular-based treatment of myelodysplastic syndromes Curr Drug Targets 6 713-725
  • [5] Steensma DP(2006)Clinical Issues in the Management of Patients with Myelodysplasia Hematology 2006 205-210
  • [6] Bennett JM(1998)Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 22 93-100
  • [7] Lindberg EH(2001)Chromosome and molecular abnormalities in myelodysplastic syndromes Int J Hematol 73 429-437
  • [8] Schiffer C. A.(2007)Myelodysplastic syndromes: the complexity of stem-cell diseases Nat Rev Cancer 7 118-129
  • [9] Aul C(2002)The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2292-2302
  • [10] Germing U(1997)International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 2079-2088
1234567